Formerly known as Lou Gehrig’s disease, amyotrophic lateral sclerosis is now commonly referred ... People with later stage disease typically require additional nursing support as well.

The candidate in question is VY9323, an AAV gene therapy combining a highly potent pri-miRNA against superoxide dismutase 1 ...

AI-generated voice clones are bringing back the voices of people with MND, allowing some to communicate, connect, and even ...

Trouble sleeping is common in other neurodegenerative diseases, but past research has only suggested that it occurs in patients with amyotrophic lateral sclerosis. | Trouble sleeping is common in ...

Multiple sclerosis (MS) in its end stages involves disabling and life threatening effects. Several home adaptations and palliative care are available and can improve survival, mobility ...

A case of a 26-year-old woman with a history (from the age of 2) of numerous, symmetrical amelanotic macules on the inguinal region, pubis, knees, and backs of the hands was admitted to the ...

A trial that will test a noninvasive device called MyoRegulator as a treatment for ALS was cleared to start enrolling ...

Nader Yaghoubi, M.D., Ph.D., PathMaker’s Co-Founder and CEO, stated, “We are pleased to announce IRB approval for the CALM study, which allows us to commence enrollments shortly. Given the mechanisms ...

The initial report of a patient with visceral scleroderma without skin involvement was published in 1954, [1] and in 1962, the term "progressive systemic sclerosis sine scleroderma" was coined.